A61K 51/00
Preparations containing radioactive substances for use in therapy or testing in vivo
A61K51/00 (Preparations containing radioactive substances for use in therapy or testing in vivo) appears on 6,893 US grants and 8,962 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,893
- Published applications
- 8,962
- Assignees
- 2,818
- Inventors
- 14,583
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 24 | 0 |
| 1977 | 29 | 0 |
| 1978 | 20 | 0 |
| 1979 | 4 | 0 |
| 1980 | 18 | 0 |
| 1981 | 23 | 0 |
| 1982 | 40 | 0 |
| 1983 | 18 | 0 |
| 1984 | 54 | 0 |
| 1985 | 29 | 0 |
| 1986 | 26 | 0 |
| 1987 | 41 | 0 |
| 1988 | 34 | 0 |
| 1989 | 70 | 0 |
| 1990 | 68 | 0 |
| 1991 | 89 | 0 |
| 1992 | 93 | 0 |
| 1993 | 85 | 0 |
| 1994 | 109 | 0 |
| 1995 | 104 | 0 |
| 1996 | 111 | 0 |
| 1997 | 165 | 0 |
| 1998 | 191 | 0 |
| 1999 | 186 | 0 |
| 2000 | 160 | 0 |
| 2001 | 138 | 42 |
| 2002 | 122 | 169 |
| 2003 | 126 | 250 |
| 2004 | 101 | 270 |
| 2005 | 101 | 277 |
| 2006 | 128 | 265 |
| 2007 | 92 | 264 |
| 2008 | 127 | 279 |
| 2009 | 117 | 319 |
| 2010 | 153 | 374 |
| 2011 | 166 | 340 |
| 2012 | 200 | 312 |
| 2013 | 258 | 388 |
| 2014 | 283 | 460 |
| 2015 | 281 | 424 |
| 2016 | 294 | 465 |
| 2017 | 324 | 391 |
| 2018 | 277 | 407 |
| 2019 | 278 | 392 |
| 2020 | 270 | 426 |
| 2021 | 247 | 411 |
| 2022 | 217 | 424 |
| 2023 | 199 | 379 |
| 2024 | 210 | 473 |
| 2025 | 214 | 426 |
| 2026 | 179 | 335 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition containing buffer6 Oct 2026US 12,752,008 B2Perseus Proteomics Inc.
- Near-infrared dyes and conjugates for targeting tumors6 Oct 2026US 12,752,023 B2Lahjavida, LLC
- Fibroblast activation protein inhibitor6 Oct 2026US 12,752,025 B2Boomray Pharmaceuticals Co., Ltd.
- Radiopharmaceutical compositions for actinium in targeted radionuclide therapy6 Oct 2026US 12,752,026 B2Curium US LLC
- Peptide libraries with non-canonical amino acids6 Oct 2026US 12,753,205 B2Regeneron Pharmaceuticals, Inc.
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Radiolabeled compounds targeting the prostate-specific membrane antigen8 Oct 2026US 2026/0306680 A1Provincial Health Services Authority
- Development of a platform to noninvasively image car t cells8 Oct 2026US 2026/0306681 A1Dana-Farber Cancer Institute, Inc.
- Radiolabeled met binding proteins for immuno-pet imaging8 Oct 2026US 2026/0306682 A1Regeneron Pharmaceuticals, Inc.
- In vivo imaging of an als biomarker and means therefor8 Oct 2026US 2026/0306683 A1AL-S Pharma AG
Most cited
By later US patents
- Medical scanning and treatment system and method1,502US 5,464,013 A1995
- Particle immobilized coatings and uses thereof1,386US 8,679,454 B2SurModics, Inc. · 2014
- Coated implantable medical device1,180US 6,096,070 ACook Incorporated · 2000
- Coated implantable medical device1,071US 5,824,049 AMED Institute, Inc. · 1998
- Silver implantable medical device1,026US 5,873,904 ACook Incorporated · 1999